Sanjay S. Reddy, MD

Request an Appointment Online - Click Here New patients can request an appointment online or call
888-FOX-CHASE

Fox Chase Cancer Center
333 Cottman Ave
Philadelphia, PA 19111

Follow on Twitter: @FCCCSurgOnc

Video: Dr. Sanjay Reddy

Sanjay Reddy, Attending Surgeon

   .

Support the work of the Department of Surgical Oncology at Fox Chase Cancer Center.
Donate Now

Patient Stories from Fox Chase Patients Dr. Reddy's
Patient Stories

Clinical Expertise:

Colorectal Cancer, Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Gastric Cancer, Melanoma, Sarcoma, Hepatobiliary Cancer, Pancreatic Cancer, General and Minimally Invasive Surgery

Certifications:

American Board of Surgery

Residencies

General Surgery, Beth Israel Medical Center, New York, NY

Fellowships

Surgical Oncology Fellow, Fox Chase Cancer Center, Temple University Hospital, Philadelphia, PA

Honors and Awards

Harriet Gold Foundation, Scholar in Humanism Award, New York Medical College, 2010 
St. Vincent’s Medical Center, New York Medical College, Resident Teaching Award, 2011 
Beth Israel Medical Center, Albert Einstein College of Medicine, Resident Teaching Award, 2011

Professional Societies

American College of Surgeons (ACS)
Clinical Robotics Surgical Association (CRSA)
Association for Academic Surgery (AAS)
American Society of Clinical Oncology (ASCO)
Society of Surgical Oncology (SSO)
Society for Surgery of the Alimentary Tract (SSAT)
Pancreas Club

Research Interests

My research interest for colorectal malignancies focuses on the use of national cancer databases to assess the accuracy of clinical staging, to see if this has improved over time, and to observe reporting standards between academic institution’s versus other centers.  As treatment of colorectal cancers involve multimodality planning, accurate clinical staging proves to be the foundation on how best to deliver care.

I also have a strong research interest in the vascular resectability staging of pancreatic cancer.  Currently under review is our preoperative venous and arterial staging for borderline resectable pancreatic cancers and whether we are able to predict from preoperative imaging the likelihood of clear margin achievement and prognosis.  As treatment of borderline resectable pancreatic cancer continues to evolve, accurate preoperative vascular resectability staging is imperative to assess and guide multimodality therapy.

Publications